SUV39H1 and breast cancer: Additionally, the KMT1A was shown to positively regulate the self-renewal and tumorigenicity of bladder CSCs in humans via the KMT1A-GATA3-STAT3 circuit, suggesting that KMT1A could be a promising target for BC therapy [105].